Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-10

Clinical Trial Update: The Efficacy and Safety of Adalimumab in Non-infectious Anterior Pediatric Uveitis With Peripheral Vascular Leakage [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of adalimumab for non-infectious anterior pediatric uveitis with peripheral vascular leakage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Uveitis, Anterior, Adalimumab | Phase 4 | Status: UNKNOWN